Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing |
Filed |
Amount |
Counted |
| 2nd Quarter - Report |
Jul 30, 2020 |
$20,000 |
Replaced |
| 2nd Quarter - Amendment (this page) |
Oct 16, 2020 |
$20,000 |
Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
| Lobbyist | Covered position, as disclosed |
| BRIAN CALLAHAN |
— |
| JANE S. TERRY |
LA to Sen. Max Cleland and Senior Policy Advisor to Rep. Denise Majette |
Contacted: White House Office; Natl Highway Traffic Safety Administration (NHTSA); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE; Occupational Safety & Health Administration (OSHA); Federal Highway Administration (FHA); Health & Human Services, Dept of (HHS); Federal Motor Carrier Safety Administration; Transportation, Dept of (DOT); Centers For Disease Control & Prevention (CDC)
FY 21 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
| Lobbyist | Covered position, as disclosed |
| BRIAN CALLAHAN New |
— |
| JANE S. TERRY |
LA to Sen. Max Cleland and Senior Policy Advisor to Rep. Denise Majette |
Contacted: Federal Highway Administration (FHA); Federal Motor Carrier Safety Administration; SENATE; Natl Highway Traffic Safety Administration (NHTSA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Occupational Safety & Health Administration (OSHA); Transportation, Dept of (DOT)
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
| Lobbyist | Covered position, as disclosed |
| BRIAN CALLAHAN New |
— |
| JANE S. TERRY |
LA to Sen. Max Cleland and Senior Policy Advisor to Rep. Denise Majette |
Contacted: Federal Highway Administration (FHA); White House Office; Centers For Disease Control & Prevention (CDC); Federal Motor Carrier Safety Administration; Natl Highway Traffic Safety Administration (NHTSA); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Transportation, Dept of (DOT); Occupational Safety & Health Administration (OSHA)
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
| Lobbyist | Covered position, as disclosed |
| BRIAN CALLAHAN New |
— |
| JANE S. TERRY |
LA to Sen. Max Cleland and Senior Policy Advisor to Rep. Denise Majette |
Contacted: Centers For Disease Control & Prevention (CDC); Occupational Safety & Health Administration (OSHA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); White House Office; Natl Highway Traffic Safety Administration (NHTSA); Transportation, Dept of (DOT); Federal Highway Administration (FHA); Federal Motor Carrier Safety Administration
Shown as published by the Senate Office of Public Records and the House Clerk under the
Lobbying Disclosure Act. The official filing is the record; open it for the full form.